Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · IEX Real-Time Price · USD
1.940
-0.030 (-1.52%)
At close: May 31, 2024, 3:58 PM
1.970
+0.030 (1.55%)
After-hours: May 31, 2024, 7:25 PM EDT
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $74.40 million as of May 31, 2024. Its market cap has decreased by -21.93% in one year.
Market Cap
74.40M
Enterprise Value
-42.76M
1-Year Change
-21.93%
Ranking
Category
Stock Price
$1.94
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $74.40M, a decrease of -87.15%. That is a compound annual growth rate of -48.55%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 74.60M | -4.48% |
May 30, 2024 | 78.10M | -4.29% |
May 29, 2024 | 81.60M | -7.48% |
May 28, 2024 | 88.20M | 2.20% |
May 24, 2024 | 86.30M | -2.15% |
May 23, 2024 | 88.20M | -1.78% |
May 22, 2024 | 89.80M | 6.90% |
May 21, 2024 | 84.00M | -10.26% |
May 20, 2024 | 93.60M | 2.07% |
May 17, 2024 | 91.70M | -3.37% |
May 16, 2024 | 94.90M | 9.33% |
May 15, 2024 | 86.80M | -4.19% |
May 14, 2024 | 90.60M | -0.98% |
May 13, 2024 | 91.50M | 0.66% |
May 10, 2024 | 90.90M | -0.66% |
May 9, 2024 | 91.50M | 3.51% |
May 8, 2024 | 88.40M | - |
May 7, 2024 | 88.40M | 2.79% |
May 6, 2024 | 86.00M | 1.42% |
May 3, 2024 | 84.80M | 1.56% |
May 2, 2024 | 83.50M | -2.45% |
May 1, 2024 | 85.60M | 7.27% |
Apr 30, 2024 | 79.80M | -20.83% |
Apr 29, 2024 | 100.80M | 3.60% |
Apr 26, 2024 | 97.30M | 2.96% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
IO Biotech | 77.74M |
Anixa Biosciences | 77.52M |
HOOKIPA Pharma | 76.66M |
Spero Therapeutics | 76.66M |
MDxHealth | 75.04M |
Tempest Therapeutics | 73.76M |
Aclaris Therapeutics | 73.40M |
Burning Rock Biotech | 73.24M |